The DOI matches its Crossref record.
Correlation Between Minimal Secretory Capacity of Pancreatic β-Cells and Stability of Diabetic Control
Abstract
The significance of the minimal secretory capacity of pancreatic β-cells for the stability of the plasma glucose level was studied in 20 patients with insulin-dependent diabetes mellitus. Changes in plasma concentrations of major counterregulatory hormones in response to hypoglycemia were also investigated in these patients to clarify their contribution to diabetic brittleness. β-Cell function was evaluated on the basis of elevation of plasma C-peptide immunoreactivity (CPR) during the intravenous glucagon test with a highly sensitive assay for plasma CPR that could detect as little as 0.03 ng/ml. After stimulation with glucagon, a significant increase in plasma CPR was observed in 10 of the patients whose β-cell function had been evaluated as completely depleted by a conventional assay for plasma CPR. A clear inverse correlation was found between the secretory capacity of pancreatic β-cells measured in this way and the degree of glycemic instability (r = −.74, P < .01). Infusion of insulin at a rate of 0.15 U.kg−1.h−1 for 60 min caused a continuous decrease in the plasma glucose level, resulting in neuroglycopenia in 7 of the 10 CPR nonresponders but only 2 of the CPR responders. During insulin-induced hypoglycemia, plasma glucagon immunoreactivity did not increase in the CPR nonresponders but increased significantly in the CPR responders. A positive correlation was found between the minimal residual β-cell capacity and the responsiveness of α-cells to hypoglycemia (r = .65, P < .01).In contrast to the difference in the responses of their pancreatic α-cells to hypoglycemia, the two groups showed more or less the same responses of plasma epinephrine, norepinephrine, growth hormone, and cortisol to hypoglycemia. Total lack of insulinogenic reserve inevitably results in loss of automatic regulation of the circulating insulin level and seems to be a major factor in causing hyperlability of diabetic control. The lack of β-cell function may be related causally to pancreatic α-cell dysfunction, which also contributes in part to metabolic variability in brittle diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the risk of hypoglycaemia in T1D is reduced as long as circulating C-peptide levels (reflecting endogenous β-cell function) remain ≥15% of normal8,42,43, in good agreement with our in silico simulations.”
From Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes (2024) · cites this paper as [43]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J. P., Dralle, H., Ebeling, P. R., Melmed, S. K., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,500
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C., Hamilton, J. K., HAY, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,273
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 406
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Federici, M., Hribal, M. L., Perego, L., Ranalli, M., Caradonna, Z., Perego, C., Usellini, L., Nano, R., Bonini, P., Bertuzzi, F., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1290 · Cited by 333
Lachin, J. M., McGee, P., Palmer, J. P., & for the DCCT/EDIC Research Group (2014) · Diabetes · doi:10.2337/db13-0881 · Cited by 283
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Saisho, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.109 · Cited by 263
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
Cryer, P. E. (2012) · Endocrinology · doi:10.1210/en.2011-1499 · Cited by 242
Sämann, A., Mühlhauser, I., Bender, R., Kloos, C., & Müller, U. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1905-1 · Cited by 226
Hypoglycemia in Type 1 Diabetes
McCrimmon, R. J., & Sherwin, R. S. (2010) · Diabetes · doi:10.2337/db10-0103 · Cited by 225
Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
Saisho, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018381 · Cited by 204
Banarer, S., McGregor, V. P., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.4.958 · Cited by 194
Hypoglycemia: Still The Limiting Factor in the Glycemic Management of Diabetes
Cryer, P. E. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.750 · Cited by 184
Intensified insulin therapy and the risk of severe hypoglycaemia
Bott, S., Bott, U., Berger, M., & Mühlhauser, I. (1997) · Diabetologia · doi:10.1007/s001250050769 · Cited by 180
Natural History of β-Cell Function in Type 1 Diabetes
Sherry, N., Tsai, E. B., & Herold, K. C. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s32 · Cited by 172
Hypoglycaemia in Elderly Patients with Diabetes Mellitus
Chelliah, A., & Burge, M. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421080-00003 · Cited by 166
Raju, B., & Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.3.757 · Cited by 155
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1115 · Cited by 152
Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes.
Weir, G. C., & Bonner‐Weir, S. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114574 · Cited by 148
Kielgast, U., Holst, J. J., & Madsbad, S. (2011) · Diabetes · doi:10.2337/db10-1790 · Cited by 137
High residual C-peptide likely contributes to glycemic control in type 1 diabetes
Rickels, M. R., Evans‐Molina, C., Bahnson, H. T., Ylescupidez, A., Nadeau, K. J., Hao, W., Clements, M. A., Sherr, J. L., Pratley, R. E., Hannon, T. S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134057 · Cited by 123
Central mechanisms of glucose sensing and counterregulation in defense of hypoglycemia
Stanley, S., Moheet, A., & Seaquist, E. R. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00226 · Cited by 112
Hope, K. M., Tran, P. O. T., Zhou, H., Oseid, E. A., Leroy, E., & Robertson, R. P. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1488 · Cited by 112
Subcutaneous insulin: pharmacokinetic variability and glycemic variability
Guerci, B., & Sauvanet, J.-P. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)88263-1 · Cited by 109
Zhou, H., Tran, P. O. T., Yang, S., Zhang, T., LeRoy, E., Oseid, E. A., & Robertson, R. P. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1482 · Cited by 99
Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes
Verberne, A. J. M., Korim, W. S., Sabetghadam, A., & Llewellyn‐Smith, I. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13458 · Cited by 99
Taborsky, G. J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400607 · Cited by 96
Linn, T., Geyer, R., Prassek, S., & Laube, H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923841 · Cited by 95
Preservation of β-cell function in autoantibody-positive youth with diabetes
Greenbaum, C. J., Anderson, A. M., Dolan, L. M., Mayer-Davis, E. J., Dabelea, D., Imperatore, G., Marcovina, S., Pihoker, C., & for the SEARCH Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2326 · Cited by 90
Vague, P., Picq, R., Bernal, M., Lassmann-Vague, V., & Vialettes, B. (1989) · Diabetologia · doi:10.1007/bf00265549 · Cited by 82
Ikegami, H., Babaya, N., & Noso, S. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13576 · Cited by 72
Self-citationThe mechanisms that underlie glucose sensing during hypoglycaemia in diabetes
McCrimmon, R. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02376.x · Cited by 72
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
Saisho, Y. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030923 · Cited by 75
Pancreatic α-cell dysfunction in diabetes
Burcelin, R., Knauf, C., & Cani, P. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73395-0 · Cited by 71
Gibb, F. W., McKnight, J. A., Clarke, C., & Strachan, M. W. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05099-3 · Cited by 72
Negotiating the Barrier of Hypoglycemia in Diabetes
Cryer, P. E., & Childs, B. P. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.1.20 · Cited by 64
The physiology and pathophysiology of the neural control of the counterregulatory response
Beall, C., Ashford, M. L., & McCrimmon, R. J. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00531.2011 · Cited by 63
Rabinovitch, A., & Skyler, J. S. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70022-5 · Cited by 62
Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block
Moon, J. S., & Won, K. C. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.1 · Cited by 61
Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans
Gosmanov, N. R., Szoke, E., Israelian, Z., Smith, T., Cryer, P. E., Gerich, J. E., & Meyer, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1124 · Cited by 60
Saisho, Y., Tanaka, K., Abe, T., Shimada, A., Kawai, T., & Itoh, H. (2011) · Diabetology International · doi:10.1007/s13340-011-0035-x · Cited by 58
Hypoglycemia in diabetes: common, often unrecognized.
Gabriely, I., & Shamoon, H. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.335 · Cited by 58
Niedźwiecki, P., Piłaciński, S., Uruska, A. A., Adamska, A., Naskręt, D., & Zozulińska‐Ziółkiewicz, D. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.002 · Cited by 57
Imagawa, A., Hanafusa, T., Itoh, N., Waguri, M., Yamamoto, K., Miyagawa, J.-I., Moriwaki, M., Yamagata, K., Iwahashi, H., Sada, M., et al. (1999) · Diabetologia · doi:10.1007/s001250051197 · Cited by 57
Chan, O. T. M., Paranjape, S., Czyzyk, D. J., Horblitt, A. M., Zhu, W., Ding, Y., Fan, X., Seashore, M. R., & Sherwin, R. (2011) · Diabetes · doi:10.2337/db10-1579 · Cited by 53
Paracrine signaling in islet function and survival
Hartig, S. M., & Cox, A. R. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01887-x · Cited by 65
Recovery of endocrine function after islet and pancreas transplantation
Rickels, M. R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0294-3 · Cited by 49
Murase, Y., Imagawa, A., Hanafusa, T., Iwahashi, H., Uchigata, Y., Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., Shimizu, I., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0575-y · Cited by 49
Sämann, A., Mühlhauser, I., Bender, R., Hunger-Dathe, W., Kloos, C., & Müller, U. (2006) · Diabetes Care · doi:10.2337/dc06-0751 · Cited by 47
McCrimmon, R. J., Evans, M. L., Jacob, R. J., Fan, X., Zhu, Y., Shulman, G. I., & Sherwin, R. S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2002 · Cited by 44
Alsahli, M., & Gerich, J. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.002 · Cited by 45
Cyclosporine in recent onset type I diabetes mellitus
Skyler, J. S., & Rabinovitch, A. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90016-e · Cited by 45
Nyiraty, S., Pesei, F., Orosz, A., Coluzzi, S., Vági, O. E., Lengyel, C., Ábrahám, G., Frontoni, S., Kempler, P., & Várkonyi, T. T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00174 · Cited by 46
Prevention and Correction of Hypoglycemia
Cryer, P. E. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_7 · Cited by 42
McGee, P., Steffes, M. W., Nowicki, M., Bayless, M., Gubitosi‐Klug, R., Cleary, P. A., Lachin, J. M., & Palmer, J. P. (2014) · Diabetic Medicine · doi:10.1111/dme.12504 · Cited by 37
Marren, S. M., Hammersley, S., McDonald, T. J., Shields, B. M., Knight, B., Hill, A., Bolt, R. F., Tree, T. I. M., Roep, B. O., Hattersley, A. T., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.13960 · Cited by 38
Mundinger, T. O., Mei, Q., Figlewicz, D. P., Lernmark, Å., & Taborsky, G. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00136.2003 · Cited by 36
Insulin‐dependent diabetes mellitus in older adults: Current status and future prospects
Ikegami, H., Hiromine, Y., & Noso, S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14414 · Cited by 47
Self-citationGABA and Glutamate: Their Transmitter Role in the CNS and Pancreatic Islets
Hampe, C. S., Mitoma, H., & Manto, M. U. (2018) · InTech eBooks · doi:10.5772/intechopen.70958 · Cited by 38
Li, Z., Zhang, Y., Quan, X., Yang, Z., Zeng, X., Ji, L., Sun, F., & Zhan, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154206 · Cited by 33
Hill, T. G., Gao, R., Benrick, A., Kothegala, L., Rorsman, N., Santos, C., Acreman, S., Briant, L. J., Dou, H., Gandasi, N. R., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01139-z · Cited by 37
“Nota-bly, the risk of hypoglycaemia in T1D is reduced as long as circulating C-peptide levels (reflecting endogenous β-cell function) remain ≥15% of normal 8,42,43 , in good agreement with our in silico simulations.”
Babaya, N., Noso, S., Hiromine, Y., Taketomo, Y., Niwano, F., Yoshida, S., Yasutake, S., Kawabata, Y., & Ikegami, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-83599-x · Cited by 34
Self-citationKolb, H., & Gale, E. A. M. (2001) · Diabetologia · doi:10.1007/s001250100636 · Cited by 30
Muneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Tanaka, S. A., Endo, T., Aida, K., Shimura, H., Yokomori, N., Kaneshige, M., Furuya, F., Amemiya, S., Mochizuki, M., Nakanishi, K., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1936 · Cited by 28
Koopmans, S. J., Sips, H. C. M., Krans, H. M. J., & Radder, J. K. (1996) · Diabetologia · doi:10.1007/bf00400670 · Cited by 29
Flatt, A. J., Little, S. A., Speight, J., Leelarathna, L., Walkinshaw, E., Tan, H. K., Bowes, A., Lubina-Solomon, A., Holmes‐Truscott, E., Chadwick, T. J., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0630 · Cited by 30
Panzer, J. K., Tamayo, A., & Caicedo, A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111792 · Cited by 29
Nakanishi, K., Kobayashi, T., Miyashita, H., Ohkubo, M., Sugimoto, T., Murase, T., Kosaka, K., Inouye, K., & Kono, M. (1990) · Metabolism · doi:10.1016/0026-0495(90)90302-s · Cited by 24
Beta-Cell Rest: A Strategy for the Prevention of Autoimmune Diabetes
Karlsson, F. A., & Björk, E. (1997) · Autoimmunity · doi:10.3109/08916939709003855 · Cited by 24
The Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Alpha cell function in type 1 diabetes
Hughes, D. S., & Narendran, P. (2014) · The British Journal of Diabetes · doi:10.15277/bjdvd.2014.014 · Cited by 24
Update on strategies limiting iatrogenic hypoglycemia
Bonaventura, A., Montecucco, F., & Dallegri, F. (2015) · Endocrine Connections · doi:10.1530/ec-15-0044 · Cited by 22
Baidal, D. A., Ballou, C., Rickels, M. R., Berney, T., Pattou, F. N., Payne, E. H., Barton, F. B., Alejandro, R., & CITR Investigators (2023) · Diabetes Care · doi:10.2337/dc22-1155 · Cited by 24
Beta-cell Activity and Destruction in Type 1 Diabetes
Karlsson, F. A., Berne, C., Björk, E., Kullin, M., Li, Z., Ma, J.-Y., Schölin, A., & Zhao, L. (2000) · Upsala Journal of Medical Sciences · doi:10.1517/03009734000000056 · Cited by 20
Nielens, N., Pollé, O. G., Robert, A. R., & Lysy, P. A. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5936360 · Cited by 20
Challenges in developing endpoints for type 1 diabetes intervention studies
Cernea, S., Raz, I., Herold, K. C., Hirshberg, B., Roep, B. O., Schatz, D., Fleming, G. A., Pozzilli, P., Little, R. R., Schloot, N. C., et al. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1002 · Cited by 20
Genetics and pathogenesis of type 1 diabetes: prospects for prevention and intervention
Ikegami, H., Noso, S., Babaya, N., & Kawabata, Y. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00176.x · Cited by 21
Self-citationShibasaki, S., Imagawa, A., Terasaki, J., & Hanafusa, T. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00059.x · Cited by 19
Acute Metabolic Complications in Diabetes
Rewers, A. (2018) · Europe PMC (PubMed Central) · Cited by 19
Farhy, L. S., Du, Z., Zeng, Q., Veldhuis, P. P., Johnson, M. L., Brayman, K. L., & McCall, A. L. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90372.2008 · Cited by 19
Cryer, P. E., & Arbeláez, A. M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch35 · Cited by 19
Miya, A., Nakamura, A., Handa, T., Nomoto, H., Kameda, H., Cho, K. Y., Nagai, S., Miyoshi, H., & Atsumi, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13426 · Cited by 18
Farhy, L. S., & McCall, A. L. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01455.x · Cited by 17
Sämann, A., Lehmann, T., Kloos, C., Braun, A., Hunger-Dathe, W., Wolf, G., & Müller, U. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02406.x · Cited by 17
Iwasaki, S., Kozawa, J., Fukui, K., Iwahashi, H., Imagawa, A., & Shimomura, I. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.021 · Cited by 17
Fan, X., Ding, Y., Cheng, H. M., Gram, D. X., Sherwin, R. S., & McCrimmon, R. J. (2008) · Diabetes · doi:10.2337/db08-0793 · Cited by 16
Miya, A., Nakamura, A., Handa, T., Nomoto, H., Kameda, H., Cho, K. Y., Nagai, S., Ito, Y. M., Miyoshi, H., & Atsumi, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-88749-9 · Cited by 16
An Implantable Subcutaneous Glucose Sensor Array in Ketosis‐prone Rats: Closed Loop Glycemic Control
Ward, W. K., Wood, M. D., Casey, H. M., Quinn, M. J., & Federiuk, I. F. (2005) · Artificial Organs · doi:10.1111/j.1525-1594.2005.29024.x · Cited by 16
Time course of the defective α-cell response to hypoglycemia in diabetic BB rats
Jacob, R. J., Dziura, J., Morgen, J., Shulman, G. I., & Sherwin, R. S. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90125-0 · Cited by 14
Sjöberg, S., Ahrén, B., & Bolinder, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01043.x · Cited by 13
Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes
Ali, M. A., & Dayan, C. M. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409351881 · Cited by 13
The C-peptide response to a standard mixed meal in a group of Brazilian type 1 diabetic patients
Pozzan, R., Dimetz, T., Gazolla, H. M., & Gomes, M. B. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997001000005 · Cited by 13
Chapter 21 Pancreatic Network Control of Glucagon Secretion and Counterregulation
Farhy, L. S., & McCall, A. L. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)67021-x · Cited by 12
Metadata
- Authors
- Fukuda, M., Tanaka, A., Tahara, Y., Ikegami, H., Yamamoto, Y., Kumahara, Y., & Shima, K.
- Affiliations
- The University of Osaka (JP)
- Tokushima University (JP)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1988-01-01
- Volume
- 37
- Issue
- 1
- Pages
- 81-88
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2074943120
- Cited by
- 145
- References
- 0
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 2 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 5 · 2012: 5
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, beta-cell function, residual beta-cell function, glycemic variability, hypoglycemia, glucagon stimulation test, C-peptide, alpha-cell dysfunction, counterregulatory hormones, glucagon, neuroglycopenia, insulin-induced hypoglycemia
- MeSH terms
- Adult, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 1, Epinephrine, Female, Glucagon, Humans, Hydrocortisone, Insulin, Islets of Langerhans, Kinetics, Male, Middle Aged, Norepinephrine, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review